Claudin-4 Expression Predicts Survival in Pancreatic Ductal Adenocarcinoma

By Tsutsumi Kosuke   Sato Norihiro   Tanabe Reiko   Mizumoto Kazuhiro   Morimatsu Katsuya   Kayashima Tadashi   Fujita Hayato   Ohuchida Kenoki   Ohtsuka Takao   Takahata Shunichi   Nakamura Masafumi   Tanaka Masao  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 491-499

Springer Publishing Company

Access to resources Recommend Favorite

Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach

By Kushima Ryoji   Vieth Michael   Borchard Franz   Stolte Manfred   Mukaisho Ken-ichi   Hattori Takanori  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 177-184

Springer Publishing Company

Access to resources Recommend Favorite

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma

By Okita Natsuko  

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of Id1 expression by epigallocatechin3gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells

By Ma Jun   Shi Min   Li Guangming   Wang Na   Wei Jue   Wang Ting   Ma Jiali   Wang Yugang  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-10 ,pp. : 1052-1058

Spandidos Publications

Access to resources Recommend Favorite

Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity

By                  

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1583-1593

Spandidos Publications

Access to resources Recommend Favorite